Recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) is widely
considered as a terminal condition. Therefore, the role of surgery is uncertain in this case …

Aim Microvascular invasion (MVI) is not discussed for solitary hepatocellular carcinoma
(HCC) up to 2 cm in the 8th Edition of the American Joint Committee on Cancer Staging …

AIM To investigate whether the change in pre-/post-operation serum alpha-fetoprotein (AFP)
levels is a predictive factor for hepatocellular carcinoma (HCC) outcomes. METHODS We …

Background High alpha-fetoprotein (AFP) expressions (> 400 ng/mL) are associated with
poor oncological characteristics for hepatocellular carcinoma (HCC). However, prognosis …

Background Direct-acting antivirals (DAAs) therapy against hepatitis C viral (HCV) infection
has markedly improved the sustained viral response. However, recent studies have …

Background Postoperative early recurrence (ER) is a major obstacle to long-term survival
after curative liver resection (LR) in patients with hepatocellular carcinoma (HCC). This study …

Background Assessing the outcomes of surgeries for hepatocellular carcinoma (HCC)
patients who exceed the Milan criteria is necessary. Some studies have demonstrated that …

Background Liver transplantation (LT) is an accepted therapeutic option for hepatocellular
carcinoma (HCC) in patients with cirrhosis. Despite careful candidate selection, HCC …

Background The value of serum biomarkers, particularly alpha-fetoprotein (AFP) and protein
induced by vitamin K absence or antagonist-II (PIVKA-II), gains increasing attention in …

Background Alpha-fetoprotein (AFP) is a well-identified biomarker in hepatocellular
carcinoma (HCC). However, only limited AFP-related studies have evaluated its early …